(2E)-3-(2,4-dimethoxyphenyl)-1-(2-methoxyphenyl)prop-2-en-1-one, 95.0%, 10g

((3S,5R)-5-((1H-1,2,4-Triazol-1-yl)methyl)-5-(2,4-difluorophenyl)tetrahydrofuran-3-yl)methyl 4-methylbenzenesulfonate, 97%, 100mg

4-(ALLYLOXY)-2-FLUOROBENZONITRILE, 95.0%, 2g

2,3,5-Trimethyl-4-nitropyridine N-Oxide>98.0%(GC)(T)250mg

ETHYL 6-BROMO-2-METHYLIMIDAZO[1,2-A]PYRIDINE-3-CARBOXYLATE, 95.0%, 250mg

Colonna capillare per GC ROTI®Cap-5, 50 m, 0,32 mm, 0,35 µm, 1 Pezzo(i)

2-Amino-6-bromo-1,8-naphthyridine, 95.0%, 250mg

4-Hydroxy-3-methyl-4,5,6,7-tetrahydro-1-benzofuran-2-carboxylic acid, 95.0%, 250mg

4-((4,4-Dimethylpiperidin-1-yl)methyl)-2-methoxybenzoic acid, 98%, 50mg

(R)-2-(Dimethylamino)-2-phenylacetic acid hydrochloride, 95%, 500mg

2,2,2-Trichloro-1-phenylethyl acetate, 95.0%, 100g

tert-Butyl (3-aminobicyclo[1.1.1]pentan-1-yl)carbamate hydrochloride, 98%, 250mg

Isopropyl Sulfide>98.0%(GC)10mL